Fusion Genomics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

Fusion Genomics General Information

Description

Operator of a molecular diagnostics company intended to transform infectious diseases through genomic technologies. The company develops molecular diagnostics specializing in next-generation sequencing for the medical, agriculture, and environmental monitoring sectors, enabling researchers to prevent unnecessary deaths from infectious diseases and halt the growing problem of drug resistance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 13888 Wireless Way
  • Suite 203
  • Richmond, British Columbia V6V 0A3
  • Canada
+1 (604)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Corporate Office
  • 13888 Wireless Way
  • Suite 203
  • Richmond, British Columbia V6V 0A3
  • Canada
+1 (604)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fusion Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 01-Jan-2025 Completed Generating Revenue
7. Later Stage VC (Series A) Completed Product In Beta Test
6. Angel (individual) 16-Dec-2021 Completed Product In Beta Test
5. Grant 09-Jan-2020 Completed Startup
4. Accelerator/Incubator Completed Startup
3. Angel (individual) 01-Mar-2016 Completed Startup
2. Accelerator/Incubator 13-Aug-2014 Completed Startup
1. Angel (individual) 26-Mar-2014 Completed Startup
To view Fusion Genomics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Fusion Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a molecular diagnostics company intended to transform infectious diseases through genomic technologies. The
Discovery Tools (Healthcare)
Richmond, Canada
12 As of 2022

Paris, France
 

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fusion Genomics Competitors (2)

One of Fusion Genomics’s 2 competitors is PathoQuest, a Formerly VC-backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PathoQuest Formerly VC-backed Paris, France
Karius Venture Capital-Backed Redwood City, CA
You’re viewing 2 of 2 competitors. Get the full list »

Fusion Genomics Patents

Fusion Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3016222-A1 System and process for data-driven design, synthesis, and application of molecular probes Pending 01-Mar-2016
EP-3423463-A1 System and process for data-driven design, synthesis, and application of molecular probes Inactive 01-Mar-2016
EP-3423463-A4 System and process for data-driven design, synthesis, and application of molecular probes Inactive 01-Mar-2016
US-11728009-B2 System and process for data-driven design, synthesis, and application of molecular probes Active 01-Mar-2016
US-20190080049-A1 System and process for data-driven design, synthesis, and application of molecular probes Active 01-Mar-2016 G16B30/00
To view Fusion Genomics’s complete patent history, request access »

Fusion Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fusion Genomics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
WUTIF Capital Angel Group Minority
Xavaav Capital Venture Capital Minority
CQDM Not-For-Profit Venture Capital Minority
Canadian Entrepreneurs in Life Science Accelerator/Incubator
To view Fusion Genomics’s complete investors history, request access »

Fusion Genomics FAQs

  • When was Fusion Genomics founded?

    Fusion Genomics was founded in 2013.

  • Where is Fusion Genomics headquartered?

    Fusion Genomics is headquartered in Richmond, Canada.

  • What is the size of Fusion Genomics?

    Fusion Genomics has 12 total employees.

  • What industry is Fusion Genomics in?

    Fusion Genomics’s primary industry is Discovery Tools (Healthcare).

  • Is Fusion Genomics a private or public company?

    Fusion Genomics is a Private company.

  • What is Fusion Genomics’s current revenue?

    The current revenue for Fusion Genomics is .

  • How much funding has Fusion Genomics raised over time?

    Fusion Genomics has raised $15.4M.

  • Who are Fusion Genomics’s investors?

    WUTIF Capital, Xavaav Capital, CQDM, and Canadian Entrepreneurs in Life Science have invested in Fusion Genomics.

  • Who are Fusion Genomics’s competitors?

    PathoQuest and Karius are competitors of Fusion Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process